- Home
- Equipment
- usa maryland
- autoimmune
Refine by
Autoimmune Equipment Supplied In Usa Maryland
9 equipment items found
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
For the qualitative and semi-quantitative determination of circulating rheumatoid factor in human serum6413 - 192 Determinations Kit - Methodology ...
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
For the detection and titration of to antimitochondrial IgG antibodies in human sera902080 - 48 Determinations Kit, 12 x 4 Well Slides - Methodology IFA. 902090 - 12 x 4 Well Slides Only - Methodology IFA. 904260 - 48 Determinations Kit, 12 x 4 Well Slides (Mouse Kidney, Mitochondrial Antibody) - Methodology IFA. 904270 - 96 Determinations Kits, 12 x 8 Well Slides (Mouse Kidney, Mitochondrial ...
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
For the detection and semi-quantitation of anti-neutrophil cytoplasmic anbodies (ANCA) in human serum904200 - 60 Determinations Kit, 10 x 6 Well Slides (Human granulocyte, ethanol fixed) - Methodology IFA. ...
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
An enzyme-linked immunosorbent assay (ELISA) designed for the quantitative measurement of circulating IgA autoantibodies to cardiolipin66015 - 480 Determinations Kit (5 x 96 Well) - Methodology EIA. 66025 - 96 Determinations Kit, Lyophilied Reagents - Methodology ...
by:AbelZeta Inc. based inRockville, MARYLAND (USA)
PRODUCT: C-CAR168. INDICATION: Autoimmune. PLATFORM: CAR-T. PRECLINICAL: CD20 / BCMA. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
Manufactured by:Aurinia Pharmaceuticals Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
BAFF and APRIL promote B cell survival and differentiation and have been shown to play a prominent role in the pathogenesis of certain autoimmune and nephrology conditions. AUR200 is currently undergoing pre-clinical development with projected submission of an IND to the FDA in ...
Manufactured by:Aurinia Pharmaceuticals Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
AUR300 acts to reduce M2 dysregulation and decrease inflammatory cytokines, and therefore may have significant clinical applications for autoimmune and fibrotic diseases. It is anticipated that clinical development for AUR300 will commence during the first half of ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1500 is being studied and evaluated for its role in preventing or treating organ transplant rejection and for treating autoimmune ...
Manufactured by:Orgenesis Inc. based inGermantown, MARYLAND (USA)
Our POCare Platform overcomes conventional processing challenges by enabling sterile, scalable onsite processing for a pipeline of advanced ...